Massachusetts General Hospital

Site:	Massachusetts General Hospital	Go to their website
Address:	55 Fruit Street
City:	Boston
State:	MA
Zip:	02114
Country:	USA

Phase [asc]	Trial	Trial Status	Site Status	Drug	NCT#
3	A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy (StrateGIST 3)	Recruiting	Active	IDRX-42	NCT07218926
1/2	Phase I/II Study of PDR001 in Patients With Advanced Malignancies	Active, not recruiting	Closed	PDR001	NCT02404441
1/2	Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors	Terminated	Closed	CB-839 + Talazoparib	NCT03875313